The Problem With IMS Health V. Ayotte

Law360, New York (February 9, 2009, 12:00 AM EST) -- On Nov. 18, 2008, a three-judge panel of the U.S. Court of Appeals for the First Circuit overturned a well-reasoned decision by Judge Paul Barbadoro in the District of New Hampshire[1] holding a state statute violates the First Amendment by prohibiting the transfer of prescriber-identifiable information for use by pharmaceutical sales representatives in the course of detailing prescription drugs.

IMS Health Inc. v. Ayotte, No. 07-1945, 2008 WL 4911262 (1st Cir. 2008), pet. for rehearing and rehearing en banc denied (1st Cir. Jan. 14, 2009)....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.